Uncoupled anti-HIV and immune-enhancing effects when combining IFN-α and IL-7

Journal of Immunology

Volumn 175, Issue 6, 2005, Pages 3724-3736

  Audigé, Annette ^a   Schlaepfer, Erika ^a   Joller, Helen ^a   Speck, Roberto F ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; CD4 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 7;

ADULT; ANTIVIRAL ACTIVITY; ARTICLE; CELL CULTURE; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG POTENCY; EX VIVO STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOTHESIS; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOTHERAPY; LYMPHOCYTE; LYMPHOCYTE FUNCTION; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS REACTIVATION; VIRUS REPLICATION; VIRUS STRAIN;

EID: 24744442335     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.6.3724     Document Type: Article

References (81)

1. + T cells in HIV-1-infected patients receiving highly active anti-retroviral therapy. Nat. Med. 5: 651-655.
2. Scripture-Adams, D. D., D. G. Brooks, Y. D. Korin, and I. A. Zack. 2002. Interleukin-7 induces expression of latent human immunodeficiency virus type 1 with minimal effects on T-cell phenotype. J. Virol. 76: 13077-13082.
3. Brooks, D. G., D. H. Hamer, P. A. Arlen, L. Gao, G. Bristol, C. M. Kitchen, E. A. Berger, and J. A. Zack. 2003. Molecular characterization, reactivation, and depletion of latent HIV. Immunity 19: 413-423.
4. Wang, F. X., Y. Xu, J. Sullivan, E. Souder, E. G. Argyris, E. A. Acheampong, J. Fisher, M. Sierra, M. M. Thomson, R. Najera, et al. 2005. IL-7 is a potent and proviral strain-specific inducer of latent HIV-1 cellular reservoirs of infected individuals on virally suppressive HAART. J. Clin. Invest. 115: 128-137.
5. Saito, Y., L. R. Sharer, L. G. Epstein, J. Michaels, M. Mintz, M. Louder, K. Golding, T. A. Cvetkovich, and B. M. Blumberg. 1994. Overexpression of nef as a marker for restricted HIV-1 infection of astrocytes in postmortem pediatric central nervous tissues. Neurology 44: 474-481.
6. Tornatore, C., R. Chandra, J. R. Berger, and E. O. Major. 1994. HIV-1 infection of subcortical astrocytes in the pediatric central nervous system. Neurology 44: 481-487.
7. Trillo-Pazos, G., A. Diamanturos, L. Rislove, T. Menza, W. Chao, P. Belem, S. Sadiq, S. Morgello, L. Sharer, and D. J. Volsky. 2003. Detection of HIV-1 DNA in microglia/macrophages, astrocytes and neurons isolated from brain tissue with HIV-1 encephalitis by laser capture microdissection. Brain Pathol. 13: 144-154.
8. Winston, J. A., L. A. Bruggeman, M. D. Ross, J. Jacobson, L. Ross, V. D. D'Agati, P. E. Klotman, and M. E. Klotman. 2001. Nephropathy and establishment of a renal reservoir of HIV type 1 during primary infection. N. Engl. J. Med. 344: 1979-1984.
9. + T cells in relation to HIV RNA load. J. Infect. Dis. 189: 1199-1208.
10. Douek, D. C., L. J. Picker, and R. A. Koup. 2003. T cell dynamics in HIV-1 infection. Annu. Rev. Immunol. 21: 265-304.
11. Pau, A. K., and J. A. Tavel. 2002. Therapeutic use of interleukin-2 in HIV-infected patients. Curr. Opin. Pharmacol 2: 433-439.
12. Farel, C. E., D. G. Chaitt, B. K. Hahn, J. A. Tavel, J. A. Kovacs, M. A. Polis, H. Masur, D. A. Follmann, H. C. Lane, and R. T. Davey, Jr. 2004. Induction and maintenance therapy with intermittent interleukin-2 in HIV-1 infection. Blood 103: 3282-3286.
13. Davey, R. T., Jr., R. L. Murphy, F. M. Graziano, S. L. Boswell, A. T. Pavia, M. Cancio, J. P. Nadler, D. G. Chaitt, R. L. Dewar, D. K. Sahner, et al. 2000. Immunologic and virologic effects of subcutaneous interleukin 2 in combination with antiretroviral therapy: a randomized controlled trial. J. Am. Med. Assoc. 284: 183-189.
14. Hatzakis, A., P. Gargalianos, V. Kiosses, M. Lazanas, V. Sypsa, C. Anastassopoulou, V. Vigklis, H. Sambatakou, C. Botsi, D. Paraskevis, et al. 2001. Low-dose IFN-α monotherapy in treatment-naive individuals with HIV-1 infection: evidence of potent suppression of viral replication. J. Interferon Cytokine Res. 21: 861-869.
15. Wong, G. H., J. F. Krowka, D. P. Stites, and D. V. Goeddel. 1988. In vitro anti-human immunodeficiency virus activities of tumor necrosis factor-α and interferon-γ. J. Immunol. 140: 120-124.
16. Imami, N., G. A. Hardy, M. R. Nelson, S. Morris-Jones, R. Al Shahi, C. Antonopoulos, B. Gazzard, and F. M. Gotch. 1999. Induction of HIV-1-specific T cell responses by administration of cytokines in late-stage patients receiving highly active anti-retroviral therapy. Clin. Exp. Immunol. 118: 78-86.
17. Brassard, D. L., M. J. Grace, and R. W. Bordens. 2002. Interferon-α as an immunotherapeutic protein. J. Leukocyte Biol. 71: 565-581.
18. Karpov, A. V. 2001. Endogenous and exogenous interferons in HIV-infection. Eur. J. Med. Res. 6: 507-524.
19. Akashi, K., M. Kondo, U. von Freeden-Jeffry, R. Murray, and I. L. Weissman. 1997. Bcl-2 rescues T lymphopoiesis in interleukin-7 receptor-deficient mice. Cell 89: 1033-1041.
20. Fry, T. J., and C. L. Mackall. 2002. Interleukin-7: from bench to clinic. Blood 99: 3892-3904.
21. Morrissey, P. J., P. Conlon, S. Braddy, D. E. Williams, A. E. Namen, and D. Y. Mochizuki. 1991. Administration of IL-7 to mice with cyclophosphamide- induced lymphopenia accelerates lymphocyte repopulation. J. Immunol. 146: 1547-1552.
22. Fry, T. J., B. L. Christensen, K. L. Komschlies, R. E. Gress, and C. L. Mackall. 2001. Interleukin-7 restores immunity in athymic T-cell-depleted hosts. Blood 97: 1525-1533.
23. Fry, T. J., M. Moniuszko, S. Creekmore, S. J. Donohue, D. C. Douek, S. Giardina, T. T. Hecht, B. J. Hill, K. Komschlies, J. Tomaszewski, et al. 2003. IL-7 therapy dramatically alters peripheral T-cell homeostasis in normal and SIV-infected nonhuman primates. Blood 101: 2294-2299.
24. Nugeyre, M. T., V. Monceaux, S. Beq, M. C. Cumont, R. H. Fang, L. Chene, M. Morre, F. Barre-Sinoussi, B. Hurtrel, and N. Israel. 2003. IL-7 stimulates T cell renewal without increasing viral replication in simian immunodeficiency virus-infected macaques. J. Immunol. 171: 4447-4453.
25. Smithgall, M. D., J. G. Wong, K. E. Critchett, and O. K. Haffar. 1996. IL-7 up-regulates HIV-1 replication in naturally infected peripheral blood mononuclear cells. J. Immunol. 156: 2324-2330.
26. Unutmaz, D., V. N. KewalRamani, S. Marmon, and D. R. Littman. 1999. Cytokine signals are sufficient for HIV-1 infection of resting human T lymphocytes. J. Exp. Med. 189: 1735-1746.
27. + thymocytes: a critical role for tumor necrosis factor and interleukin-7. J. Virol. 73: 7533-7542.
28. + human memory T cells. J. Immunol. 165: 716-724.
29. + T cells. Proc. Natl Acad. Sci. USA 98: 9277-9282.
30. Steffens, C. M., E. Z. Managlia, A. Landay, and L. Al Harthi. 2002. Interleukin-7-treated naive T cells can be productively infected by T-cell-adapted and primary isolates of human immunodeficiency virus 1. Blood 99: 3310-3318.
31. Ducrey-Rundquist, O., M. Guyader, and D. Trono. 2002. Modalities of interleukin-7-induced human immunodeficiency virus permissiveness in quiescent T lymphocytes. J. Virol. 76: 9103-9111.
32. + mature thymocytes correlates with their capacity to favor human immunodeficiency X4 virus replication. J. Virol. 77: 5784-5793.
33. Uittenbogaart, C. H., W. J. Boscardin, D. J. Anisman-Posner, P. S. Koka, G. Bristol, and J. A. Zack. 2000. Effect of cytokines on HIV-induced depletion of thymocytes in vivo. AIDS 14: 1317-1325.
34. Napolitano, L. A., C. A. Stoddart, M. B. Hanley, E. Wieder, and J. M. McCune. 2003. Effects of IL-7 on early human thymocyte progenitor cells in vitro and in SCID-hu Thy/Liv mice. J. Immunol. 171: 645-654.
35. Audige, A., E. Schlaepfer, A. Bonanomi, H. Joller, M. C. Knuchel, M. Weber, D. Nadal, and R. F. Speck. 2004. HIV-1 does not provoke alteration of cytokine gene expression in lymphoid tissue after acute infection ex vivo. J. Immunol. 172: 2687-2696.
36. Lyons, A. B. 2000. Analysing cell division in vivo and in vitro using flow cytometric measurement of CFSE dye dilution. J. Immunol. Methods 243: 147-154.
37. Llano, A., J. Barretina, A. Gutierrez, J. Blanco, C. Cabrera, B. Clotet, and J. A. Este. 2001. Interleukin-7 in plasma correlates with CD4 T-cell depletion and may be associated with emergence of syncytium-inducing variants in human immunodeficiency virus type 1-positive individuals. J. Virol. 75: 10319-10325.
38. Hernandez-Caselles, T., M. Martinez-Esparza, D. Sancho, G. Rubio, and P. Aparicio. 1995. Interleukin-7 rescues human activated T lymphocytes from apoptosis induced by glucocorticoesteroids and regulates bcl-2 and CD25 expression. Hum. Immunol. 43: 181-189.
39. Seki, H., K. Iwai, H. Kanegane, A. Konno, K. Ohta, A. Yachie, N. Taniguchi, and T. Miyawaki. 1995. Differential protective action of cytokines on radiation-induced apoptosis of peripheral lymphocyte subpopulations. Cell. Immunol. 163: 30-36.
40. -/- mice. Cell 89: 1011-1019.
41. + T cells. Eur. J. Immunol. 28: 3057-3065.
42. + thymocytes through sustained induction of Bcl-2. Blood 98: 2166-2174.
43. L. J. Immunol. 172: 4444-4453.
44. Carbone, F. R., and W. R. Heath. 2003. The role of dendritic cell subsets in immunity to viruses. Curr. Opin. Immunol. 15: 416-420.
45. Gatti, E., and P. Pierre. 2003. Understanding the cell biology of antigen presentation: the dendritic cell contribution. Curr. Opin. Cell Biol. 15: 468-473.
46. Linnemann, T., Y. H. Zheng, R. Mandic, and B. M. Peterlin. 2002. Interaction between Nef and phosphatidylinositol-3-kinase leads to activation of p21-activated kinase and increased production of HIV. Virology 294: 246-255.
47. + T lymphocytes and macrophages. J. Virol. 77: 2539-2549.
48. Barata, J. T., A. Silva, J. G. Brandao, L. M. Nadler, A. A. Cardoso, and V. A. Boussiotis. 2004. Activation of PI3K is indispensable for interleukin 7-mediated viability, proliferation, glucose use, and growth of T cell acute lymphoblastic leukemia cells. J. Exp. Med. 200: 659-669.
49. + T cells residing within human lymphoid tissues. Immunity 15: 671-682.
50. Schlapfer, E., M. Fischer, P. Ott, and R. F. Speck. 2003. Anti-HIV-1 activity of leflunomide: a comparison with mycophenolic acid and hydroxyurea. AIDS 17: 1613-1620.
51. Schlaepfer, E., A. Audige, B. von Beust, V. Manolova, M. Weber, H. Joller, M. F. Bachmann, T. M. Kundig, and R. F. Speck. 2004. CpG oligodeoxynucleotides block human immunodeficiency virus type 1 replication in human lymphoid tissue infected ex vivo. J. Virol. 78: 12344-12354.
52. Chawla-Sarkar, M., D. J. Lindner, Y. F. Liu, B. R. Williams, G. C. Sen, R. H. Silverman, and E. C. Borden. 2003. Apoptosis and interferons: role of interferon-stimulated genes as mediators of apoptosis. Apoptosis 8: 237-249.
53. Chan, S. L., and V. C. Yu. 2004. Proteins of the bcl-2 family in apoptosis signalling: from mechanistic insights to therapeutic opportunities. Clin. Exp. Pharmacol. Physiol. 31: 119-128.
54. Danial, N. N., and S. J. Korsmeyer. 2004. Cell death: critical control points. Cell 116: 205-219.
55. Jekle, A., O. T. Keppler, E. De Clercq, D. Schols, M. Weinstein, and M. A. Goldsmith. 2003. In vivo evolution of human immunodeficiency virus type 1 toward increased pathogenicity through CXCR4-mediated killing of uninfected CD4 T cells. J. Virol. 77: 5846-5854.
56. Geiselhart, L. A., C. A. Humphries, T. A. Gregorio, S. Mou, J. Subleski, and K. L. Komschlies. 2001. IL-7 administration alters the CD4:CD8 ratio, increases T cell numbers, and increases T cell function in the absence of activation. J. Immunol. 166: 3019-3027.
57. Tan, J. T., E. Dudl, E. LeRoy, R. Murray, J. Sprent, K. I. Weinberg, and C. D. Surh. 2001. IL-7 is critical for homeostatic proliferation and survival of naive T cells. Proc. Natl. Acad. Sci. USA 98: 8732-8737.
58. + T cells in vivo. J. Virol. 78: 9740-9749.
59. Vella, A. T., S. Dow, T. A. Potter, J. Kappler, and P. Marrack. 1998. Cytokine-induced survival of activated T cells in vitro and in vivo. Proc. Natl. Acad. Sci. USA 95: 3810-3815.
60. Rathmell, J. C., E. A. Farkash, W. Gao, and C. B. Thompson. 2001. IL-7 enhances the survival and maintains the size of naive T cells. J. Immunol. 167: 6869-6876.
61. Kondrack, R. M., J. Harbertson, J. T. Tan, M. E. McBreen, C. D. Surh, and L. M. Bradley. 2003. Interleukin 7 regulates the survival and generation of memory CD4 cells. J. Exp. Med. 198: 1797-1806.
62. Grabstein, K. H., A. E. Namen, K. Shanebeck, R. F. Voice, S. G. Reed, and M. B. Widmer. 1990. Regulation of T cell proliferation by IL-7. J. Immunol. 144: 3015-3020.
63. deGrakoui, A., S. K. Bromley, C. Sumen, M. M. Davis, A. S. Shaw, P. M. Allen, and M. L. Dustin. 1999. The immunological synapse: a molecular machine controlling T cell activation. Science 285: 221-227.
64. 2+ responses triggered in T cells by dendritic cells compared with B cells. J. Exp. Med. 188: 1473-1484.
65. Kondo, T., I. Cortese, S. Markovic-Plese, K. P. Wandinger, C. Carter, M. Brown, S. Leitman, and R. Martin. 2001. Dendritic cells signal T cells in the absence of exogenous antigen. Nat. Immunol. 2: 932-938.
66. Revy, P., M. Sospedra, B. Barbour, and A. Trautmann. 2001. Functional antigen-independent synapses formed between T cells and dendritic cells. Nat. Immunol. 2: 925-931.
67. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392: 245-252.
68. Armitage, R. J., S. F. Ziegler, M. P. Beckmann, R. L. Idzerda, L. S. Park, and W. C. Fanslow. 1991. Expression of receptors for interleukin 4 and interleukin 7 on human T cells. Adv. Exp. Med. Biol. 292: 121-130.
69. Shirazi, Y., and P. M. Pitha. 1998. Interferon downregulates CXCR4 (fusin) gene expression in peripheral blood mononuclear cells. J. Hum. Virol. 1: 69-76.
70. Cremer, I., V. Vieillard, and E. De Maeyer. 2000. Retrovirally mediated IFN-β transduction of macrophages induces resistance to HIV, correlated with up-regulation of RANTES production and down-regulation of C-C chemokine receptor-5 expression. J. Immunol. 164: 1582-1587.
71. Korin, Y. D., and J. A. Zack. 1998. Progression to the G1b phase of the cell cycle is required for completion of human immunodeficiency virus type 1 reverse transcription in T cells. J. Virol. 72: 3161-3168.
72. + T cells. Biol. Neonate 85: 3-10.
73. Hofmeister, R., A. R. Khaled, N. Benbernou, E. Rajnavolgyi, K. Muegge, and S. K. Durum. 1999. Interleukin-7: physiological roles and mechanisms of action. Cytokine Growth Factor Rev. 10: 41-60.
74. Uddin, S., E. N. Fish, D. A. Sher, C. Gardziola, M. F. White, and L. C. Platanias. 1997. Activation of the phosphatidylinositol 3-kinase serine kinase by IFN-α. J. Immunol. 158: 2390-2397.
75. Ruuth, K., L. Carlsson, B. Hallberg, and E. Lundgren. 2001. Interferon-α promotes survival of human primary B-lymphocytes via phosphatidylinositol 3-kinase. Biochem. Biophys. Res. Commun. 284: 583-586.
76. Fagard, C., M. Le Braz, H. Gunthard, H. H. Hirsch, M. Egger, P. Vernazza, E. Bernasconi, A. Telenti, C. Ebnother, A. Oxenius, et al. 2003. A controlled trial of granulocyte macrophage-colony stimulating factor during interruption of HAART. AIDS 17: 1487-1492.
77. Napolitano, L. A. 2003. Approaches to immune reconstitution in HIV infection. Top. HIV Med. 11: 160-163.
78. Unutmaz, D., P. Pileri, and S. Abrignani. 1994. Antigen-independent activation of naive and memory resting T cells by a cytokine combination. J. Exp. Med. 180: 1159-1164.
79. + T cells. J. Immunol. 162: 3256-3262.
80. + T cells. J. Exp. Med. 194: 1711-1719.
81. Tavel, J. A., I. Sereti, R. E. Walker, B. Hahn, J. A. Kovacs, S. Jagannatha, R. T. Davey, Jr., J. Falloon, M. A. Polis, H. Masur, et al. 2003. A randomized, double-blinded, placebo-controlled trial of intermittent administration of inter-leukin-2 and prednisone in subjects infected with human immunodeficiency virus. J. Infect. Dis. 188: 531-536.